Donata Santarsiero

机构：Mario Negri Institute for Pharmacological Research · ORCID：0000-0002-6423-0935

发表论文 11 篇 · 总被引 121 次 · h-index 4

代表论文

• C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19 (2021 · Blood Advances · 被引 69)
• The Complement System in Kidney Transplantation (2023 · Cells · 被引 26)
• An ex vivo test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndrome (2023 · Frontiers in Immunology · 被引 19)
• C3d-targeted complement inhibitors to correct complement dysregulation in aHUS patients (2025 · Frontiers in Immunology · 被引 4)
• Complement Alternative Pathway Dominance in Atypical Hemolytic Uremic Syndrome Revealed by Endothelial Bioassays (2025 · Kidney International Reports · 被引 3)
• Exuberant Endothelial C5b-9 Formation in Recurrent and De Novo Posttransplant Thrombotic Microangiopathy (2024 · Kidney International Reports · 被引 2)